June 25, 2020 / 12:19 PM / 9 days ago

BRIEF-VistaGen & EverInsight Enter Strategic Collaboration To Develop And Commercialize PH94B

June 25 (Reuters) - VistaGen Therapeutics Inc:

* VISTAGEN THERAPEUTICS AND EVERINSIGHT THERAPEUTICS ENTER STRATEGIC COLLABORATION TO DEVELOP AND COMMERCIALIZE PH94B FOR ANXIETY DISORDERS IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA

* VISTAGEN THERAPEUTICS - COLLABORATION INTENDED TO SUPPORT PHASE 3 DEVELOPMENT AND COMMERCIALIZATION OF PH94B IN KEY ASIAN MARKETS

* VISTAGEN THERAPEUTICS INC - AGREEMENT INCLUDES $5 MILLION UPFRONT PAYMENT AND DEVELOPMENT AND COMMERCIAL MILESTONES UP TO $172 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below